Lundbeck's migraine drug approved in EU
![Photo: Lundbeck / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13670676.ece/ALTERNATES/schema-16_9/doc7jf7zsrwshk1nfuw7njl.jpg)
Lundbeck’s migraine drug Vyepti has been approved for use in the EU, the company reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.